Source: Health Products and Food Branch (CA) Revision Year: 2019
APRESOLINE.
APRESOLINE (hydralazine hydrochloride injection Mfr. Std.) 20 mg/mL, 1 mL Solution: 1 mL clear glass vials containing clear to pale yellow sterile solution, available in cartons of 10 vials.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
SteriMax Inc., 2770 Portland Drive, Oakville, ON, L6H 6R4 227648 |
Date of revision:
August 15, 2019 |
| Drug | Countries | |
|---|---|---|
| APRESOLINE | Canada, Ireland, Japan, New Zealand, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
